Workflow
Thermo Fisher Scientific (TMO) Q1 Earnings and Revenues Beat Estimates
TMOThermo Fisher Scientific(TMO) ZACKS·2025-04-23 12:10

Company Performance - Thermo Fisher Scientific reported quarterly earnings of 5.15pershare,exceedingtheZacksConsensusEstimateof5.15 per share, exceeding the Zacks Consensus Estimate of 5.10 per share, and showing a slight increase from 5.11pershareayearago[1]−Thecompanyachievedrevenuesof5.11 per share a year ago [1] - The company achieved revenues of 10.36 billion for the quarter, surpassing the Zacks Consensus Estimate by 1.11%, and showing a marginal increase from 10.35billionyear−over−year[3]−Overthelastfourquarters,ThermoFisherhasconsistentlysurpassedconsensusEPSestimatesfourtimesandrevenueestimatesthreetimes[2][3]MarketOutlook−Thestockhasunderperformed,losingapproximately16.410.35 billion year-over-year [3] - Over the last four quarters, Thermo Fisher has consistently surpassed consensus EPS estimates four times and revenue estimates three times [2][3] Market Outlook - The stock has underperformed, losing approximately 16.4% since the beginning of the year, compared to a decline of 10.1% for the S&P 500 [4] - The current consensus EPS estimate for the upcoming quarter is 5.56, with expected revenues of 10.78billion,andforthecurrentfiscalyear,theEPSestimateis10.78 billion, and for the current fiscal year, the EPS estimate is 23.17 on revenues of $43.82 billion [8] Industry Context - The Medical - Instruments industry, to which Thermo Fisher belongs, is currently ranked in the top 35% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [9] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor sentiment and stock performance [6]